Literature DB >> 26385221

Circulating CD4+CD28null and extra-thymic CD4+CD8+ double positive T cells are independently associated with disease damage in systemic lupus erythematosus patients.

M F Ugarte-Gil1, C Sánchez-Zúñiga2, R V Gamboa-Cárdenas3, M Aliaga-Zamudio2, F Zevallos3, G Tineo-Pozo2, J M Cucho-Venegas3, A Mosqueira-Riveros2, M Medina3, R A Perich-Campos4, J L Alfaro-Lozano3, Z Rodriguez-Bellido4, G S Alarcón5, C A Pastor-Asurza4.   

Abstract

OBJECTIVE: To determine whether circulating CD4+CD28null and extra-thymic CD4+CD8+ double positive (DP) T cells are independently associated with damage accrual in systemic lupus erythematosus (SLE) patients.
METHODS: This cross-sectional study was conducted between September 2013 and April 2014 in consecutive SLE patients from our Rheumatology Department. CD4+CD28null and CD4+CD8+ DP T-cell frequencies were analyzed by flow-cytometry. The association of damage (SLICC/ACR Damage Index, SDI) and CD4+CD28null and CD4+CD8+ DP T cells was examined by univariable and multivariable Poisson regression models, adjusting for possible confounders. All analyses were performed using SPSS 21.0.
RESULTS: Patients' (n = 133) mean (SD) age at diagnosis was 35.5 (16.8) years, 124 (93.2%) were female; all were mestizo (mixed Caucasian and Amerindian ancestry). Disease duration was 7.4 (6.8) years. The SLE Disease Activity Index was 5.5 (4.2), and the SDI 0.9 (1.2). The percentages of CD4+CD28null and CD4+CD8+ DP T cells were 17.1 (14.4) and 0.4 (1.4), respectively. The percentage of CD4+CD28null and CD4+CD8+ DP T cells were positively associated with a higher SDI in both univariable (rate ratio (RR) 1.02, 95% confidence interval (CI): 1.01-1.03 and 1.17, 95% CI: 1.07-1.27, respectively; p < 0.001 for both) and multivariable analyses RR 1.02, 95% CI: 1.01-1.03, p = 0.001 for CD4+CD28null T cells and 1.28, 95% CI: 1.13-1.44, p < 0.001 for CD4+CD8+ DP T cells). Only the renal domain remained associated with CD4+CD28null in multivariable analyses (RR 1.023 (1.002-1.045); p = 0.034).
CONCLUSIONS: In SLE patients, CD4+CD28null and CD4+CD8+ DP T cells are independently associated with disease damage. Longitudinal studies are warranted to determine the predictive value of these associations.
© The Author(s) 2015.

Entities:  

Keywords:  Systemic lupus erythematosus; T lymphocytes; disease damage; immunosenescence

Mesh:

Substances:

Year:  2015        PMID: 26385221     DOI: 10.1177/0961203315604910

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  5 in total

1.  The host cellular immune response to cytomegalovirus targets the endothelium and is associated with increased arterial stiffness in ANCA-associated vasculitis.

Authors:  Dimitrios Chanouzas; Michael Sagmeister; Lovesh Dyall; Phoebe Sharp; Lucy Powley; Serena Johal; Jessica Bowen; Peter Nightingale; Charles J Ferro; Matthew D Morgan; Paul Moss; Lorraine Harper
Journal:  Arthritis Res Ther       Date:  2018-08-29       Impact factor: 5.156

Review 2.  CD28 null CD4 T-cell expansions in autoimmune disease suggest a link with cytomegalovirus infection.

Authors:  Aalia Bano; Alejandra Pera; Ahmad Almoukayed; Thomas H S Clarke; Sukaina Kirmani; Kevin A Davies; Florian Kern
Journal:  F1000Res       Date:  2019-03-25

3.  Human umbilical cord-derived mesenchymal stem cell therapy ameliorates lupus through increasing CD4+ T cell senescence via MiR-199a-5p/Sirt1/p53 axis.

Authors:  Tao Cheng; Shuai Ding; Shanshan Liu; Yan Li; Lingyun Sun
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

4.  Subclinical Reactivation of Cytomegalovirus Drives CD4+CD28null T-Cell Expansion and Impaired Immune Response to Pneumococcal Vaccination in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Authors:  Dimitrios Chanouzas; Michael Sagmeister; Sian Faustini; Peter Nightingale; Alex Richter; Charles J Ferro; Matthew David Morgan; Paul Moss; Lorraine Harper
Journal:  J Infect Dis       Date:  2019-01-07       Impact factor: 5.226

5.  Basophils as a potential marker of lupus nephritis by flow cytometry.

Authors:  Yanni Jiang; Jin Chen; Yi Zhao; Yi Liu; Hong Xu; Xianming Mo
Journal:  Future Sci OA       Date:  2021-02-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.